CCM
PRNB

Consonance Capital Management’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Consonance Capital Management’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-689,718
Closed -$41M – 42
2020
Q1 		$41M Buy
+689,718
New +$40.2M 3.05% 13

Other funds holding PRNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Consonance Capital Management's PRNB Position: Q2 2020 in Review

Consonance Capital Management sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q2 2020, closing a stake of 689,718 shares — an estimated $41M sold.

Consonance Capital Management first reported a position in PRNB in Q1 2020 and held it in 1 quarter. The position peaked at $41M in Q1 2020. 137 funds tracked by Wall St. Rank hold PRNB as of Q2 2020.

  • Consonance Capital Management reported no remaining Principia Biopharma Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Consonance Capital Management sold 689,718 Principia Biopharma Inc. Common Stock shares in Q2 2020, an estimated $41M.
  • Consonance Capital Management first reported a position in Principia Biopharma Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Consonance Capital Management's Principia Biopharma Inc. Common Stock position peaked at $41M in Q1 2020.
  • 137 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q2 2020.

Based on Consonance Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.